Tower Research Capital LLC (Trc) Biomea Fusion, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,093 shares of BMEA stock, worth $25,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,093
Previous 4,790
235.97%
Holding current value
$25,748
Previous $10,000
180.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BMEA
# of Institutions
98Shares Held
23.1MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$6.14 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.71 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.75 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.28 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.01 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $46.9M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...